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Clinical Manifestations 
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The increase and ease of globalization 
along with emerging infectious diseases 
puts populations at a higher risk for 
contracting infections capable of causing 
severe morbidity and mortality. Viral 
infections are a common source of illness 
worldwide, and the severity of illness can 
depend on many factors such as the type 
of virus, the host’s natural defense, and 
the availability of resources and 
treatments. Ebola has been a hot topic in 
the news lately as a result of the recent 
2014 outbreak in West Africa that 
eventually found its way into the United 
States. According to Bray and Chertow 
(2015) “As of June 28, 2015, the 
cumulative number of probable, 
suspected, and laboratory-confirmed 
cases attributed to Ebola virus is 27,550, 
including 11,235 deaths.” Ebola was first 
discovered in 1976 near the Ebola River 
within the Congo region of Africa (CDC, 
2015). The Ebola virus is a member of the 
filoviridae family. Five different species 
have been identified, four of which are 
known to cause disease in humans (CDC, 
2015). The Ebola virus has historically 
been termed Ebola hemorrhagic fever, 
however this term is no longer widely 
accepted due to fact that only about 1/3 
of patients who contract Ebola develop 
hemorrhaging (Rougeron, Feldmann, 
Grard, Becker & Leroy, 2014). Rapid action 
and containment along with a touch of 
luck prevented a possible epidemic in the 
United States, but does not mean we are 
immune to another potential threat in the 
future. Additionally, our country has been 
in a war for well over a decade with 
seemingly no end in sight. The aftermath 
of September 11th, 2001 lingers on, and 
the reality of continued terrorism remains 
a fear for the majority of Americans. We 
have come to understand that many of 
these terrorists who plan to do harm to 
our nation live in our communities. This 
reality makes the threat of terrorism even 
more frightening, and bioterrorism is no 
exception. While the debate remains, the 
recent outbreak of Ebola has many 
bioterrorism experts concerned over the 
possibility of ‘weaponizing’ the highly 
infectious agent, which would 
undoubtedly wreak havoc on our nation. 
While the news has seemed to steer away 
from talking about Ebola, we must not let 
our guard down. As health care 
professionals, we should familiarize 
ourselves with pathophysiologic concepts 
regarding Ebola should an epidemic occur. 
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Conclusion 
The medical community, including 
nurses and advanced practice nurses are 
frontline clinicians that need to be 
properly educated to better understand 
the pathogenesis of the Ebola virus. This 
understanding leads to better care for 
patients and can prevent further spread of 
the disease should an outbreak occur. 
With terror threats becoming increasingly 
frequent, the nursing community must not 
rule out Ebola as a potential disease agent 
of warfare targeted at Americans. 
Additionally, Ebola should be considered a 
diagnosis in patients presenting with signs 
of infection that have recently traveled 
internationally or been exposed to 
someone with the virus (Martines, et al., 
2015). Highly infectious diseases such as 
Ebola require the highest level of clinical 
preparedness to adequately triage and 
prevent a possible pandemic. Working 
closely with local, state, and federal 
Nursing Implications 
J.M is a 34-year-old E.R nurse who is employed at a large 
metropolitan hospital in Columbus, Ohio. J.M cared for a middle-
aged man approximately one week ago who embarked on a mission 
trip to West Africa educating the community on the prevention of 
sexually transmitted infections (STI’s). This patient’s health rapidly 
declined and he ultimately expired in the hospital for reasons that 
are currently being investigated by the coroner. The patient was 
placed under strict isolation, however he was not in isolation while 
under the care of J.M. J.M now presents to the urgent care with 
complaints of generalized weakness, fatigue, myalgia, abdominal 
pain, diarrhea and vomiting that began approximately 3 days ago 
and her symptoms have progressively worsened. She states that the 
flu has been going around at work.  
Case Study 
Ebola virus has an incubation period of 
2 to 21 days, but generally causes sudden 
symptoms an average of 6 to 12 days post 
exposure (Bray & Chertow, 2015). Early 
symptoms are nonspecific and include flu-
like symptoms such as fever, chills, and 
general malaise (Martines, et al., 2015). 
These early symptoms are often difficult to 
distinguish between other viral infections 
making it challenging to diagnose early. As 
the disease progresses, gastrointestinal 
symptoms such as anorexia, nausea, 
vomiting, and diarrhea become apparent 
along with the development of a rash, 
cough, and jaundice (Feldmann & Gesibert, 
2011). Patients can also experience an 
altered level of consciousness and seizure 
activity along with a diffuse erythematous 
rash (Bray & Chertow, 2015). These 
symptoms generally indicate that the virus 
has affected multiple organ systems. 
Hemorrhagic signs and symptoms are only 
seen approximately one third of infected 
patients, is often considered the fatal stage 
of the disease course, and manifests as 
mucous membrane bleeding, epistaxis, and 
hematemesis (Rougeron, et al., 2014). “The 
systemic virus spread and replication, the 
general dysregulation of the host immune 
response, the coagulation abnormalities, 
the impairment of the vascular system, and 
hypotension all together finally result in 
shock and multiorgan failure” (Feldmann & 
Geisbert, 2011, p. 853). 
J.M was a previously healthy, well-developed individual with no 
past medical or surgical history. J.M is a nonsmoker, drinks alcohol 
only on occasion, and denies illicit drug use. Vitals signs are blood 
pressure 98/52, heart rate 124 beats/minute, respiratory rate 34 
breaths/minute, temperature 102.4° F, oxygen saturation 96% on 
room air. Physical exam reveals J.M is alert, oriented x 3. She appears 
to be in moderate distress. She is tachypneic and diaphoretic. Lungs 
are clear to auscultation bilaterally, no use of accessory muscles. She 
has a moist cough. Cardiovascular exam reveals RRR with no clicks, 
rubs, or murmurs noted, no JVD, and she has no peripheral edema. 
Bowel sounds are hyperactive. Abdomen is soft, nontender. No 
organomegaly is detected. At the urgent care, rapid strep test was 
negative. CBC and chem 7 is unremarkable. Portable chest x-ray 
reveals no infiltrates or atelectasis. Due to the fact that she recently 
cared for an individual who became critically ill shortly after returning 
from an international trip, she is sent to the nearest emergency 
department for further testing and care. J.M is immediately placed in 
negative pressure isolation. A polymerase chain reaction (PCR) assay 
is conducted at the hospital and is positive.  
Above: Colorized transmission electron micrograph (TEM) 
representing an Ebola virus virion.  
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Once the virus enters the body, it can 
quickly invade and affect nearly all cell 
types including epithelial cells, dendritic 
cells, monocytes, hepatocytes and 
endothelial cells (Bray & Chertow, 2015). 
Macrophages and monocytes are 
thought to be the first cells to be 
infected, causing the release of pro-
inflammatory cytokines (Rougeron, et al., 
2014). While lymphocytes are not 
directly infected, apoptosis of this cell 
type is commonly seen with this disease 
leading to a deficient adaptive immune 
response (Feldmann & Geisbert, 2011). 
The virus invades the host through 
damaged skin or mucous membranes 
and attaches to the host’s receptor cell 
where it then penetrates the cell through 
endocytosis, uncoats itself, and is then 
transcribed into positive-strain mRNA 
(Jarrett, 2014). The rapid replication of 
the virus within the host’s receptor cell 
leads to cellular necrosis with 
subsequent release of a large number of 
new viral particles into the surrounding 
space (Bray & Chertow, 2015). “In cases 
of severe infection, there is a massive 
release of pro-inflammatory mediators 
and vasoactive substances, which 
promotes inflammation and coagulation 
but renders the immune system unable 
to effectively prevent systemic spread of 
the virus.” In late stages of the disease, 
infected macrophages release tissue 
factor causing disseminated intravascular 
coagulation (Rougeron, et al., 2014). The 
multiplied virions now in the 
extracellular fluid are then able to travel 
to various organ systems including the 
liver, spleen, kidneys, and bone marrow 
where they are capable of causing end-
organ damage and destruction ultimately 
leading to shock and death.  
The Ebola virus is a member of the 
filoviridae family. Five distinctive species 
of ebolavirus have been identified, four of 
which are known to cause disease in 
humans (Martines, Ng, Greer, Rollin, and 
Zaki, 2014). The specific species known to 
cause disease in humans are Zaire, Sudan, 
Ivory Coast, and Bundibugyo (Bray & 
Chertow, 2014). Bah et al. (2015) report 
that the Zaire ebolavirus (EBOV) was the 
cause of the most recent West African 
outbreak and carries the highest human 
mortality rate among the five known 
species, with up to 90% of cases being 
fatal. Ebola is a filamentous, enveloped, 
single-stranded, negative-sense RNA virus 
(Martines, et al., 2014). According to 
Jarrett (2014), just ten Ebola microbes are 
needed to successfully transmit the virus 
from human to human, proving it to be 
highly capable of infectivity. “Outbreaks 
typically originate with introduction of 
the virus into humans from a wild animal 
reservoir, with subsequent human-to-
human transmission, often fueled by 
nosocomial amplification in resource-
poor settings” (Bah, et al., 2015, p. 40). 
Ebola can be spread by direct contact 
with various infected animal species 
including primates and bats, however the 
virus is not spread via the airborne route 
(CDC, 2014). Fruit bats are considered to 
be reservoirs of Ebola virus. After the 
initial transmission from animal to 
human, Ebola spreads “via direct contact 
(through broken skin or mucous 
membranes) with the blood, secretions, 
organs or other bodily fluids of infected 
people, and with surfaces and materials 
contaminated with these fluids” (Nault, 
2014). 
government healthcare agencies can aid 
in the prevention and contamination of 
an outbreak. The research conducted by 
Bah, et al. (2015), found that age was the 
greatest predictor of outcome in those 
with Ebola virus. The study of 37 patients 
revealed the mean age of survivors who 
were diagnosed with the Ebola virus in 
Conakry, Guinea was 26 compared to the 
older mean age of 45 among nonsurvivors 
(Bah, et al., 2015). While treating others 
is important, perhaps the most crucial 
aspect of infectious disease outbreaks 
capable to producing widespread illness 
such as Ebola that the medical community 
must consider is protecting oneself. 
Anyone suspected of having Ebola ought 
to be immediately isolated, and those 
caring for the individual must adhere to 
strict protocols such as being fully 
covered with protective clothing and a 
respirator, in addition to properly 
washing hands and carefully cleaning and 
disinfecting potentially infected surfaces 
and equipment (Pringle, 2015). 
Clearly, the Ebola virus is capable of 
producing widespread morbidity and 
mortality. While the recent outbreak of 
Ebola virus that penetrated American 
cities was terrifying and had the 
capability of causing an epidemic, the 
medical community and healthcare 
organizations learned a great deal about 
the disease. This newfound respect for 
Ebola has sparked a desire for better 
treatment options including the 
development of a vaccine, leading to not 
only better health for Americans, but also 
better outcomes for those in poor and 
underserved countries in Africa. 
Moreover, with continued terror threats 
against the United States, we should not 
rule out the possibility of Ebola being 
used as a biological weapon.  
Above: Map of West Africa depicting the # of days since the last 
confirmed case of Ebola virus as of July 12, 2015. © WHO, 2015 
